Lawrence R. Wechsler

Lawrence R. Wechsler

Auto-generated profile, based on publicly available information

Lawrence R. Wechsler

Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia (L.R.W.).

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2008 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
WKWataru Kakuda
Wataru Kakuda
MLMaarten G Lansberg
Maarten G Lansberg
VTVincent N Thijs
Vincent N Thijs
SKStephanie M Kemp
Stephanie M Kemp
RBRoland Bammer
Roland Bammer
OIon behalf of The DEFUSE Investigators
on behalf of The DEFUSE Investigators
Although the perfusion-weighted imaging/diffusion-weighted imaging (PWI/DWI) mismatch model has been proposed to identify acute stroke patients who benefit from reperfusion therapy, the optimal definition of a mismatch is uncertain. We evaluated the odds ratio for a favorable clinical response in mismatch patients with reperfusion compared with no reperfusion for various mismatch ratio thresholds in patients enrolled in the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. A mismatch ratio of 2.6 provided the highest sensitivity (90%) and specificity (83%) for identifying patients in whom reperfusion was associated with a favorable response. Defining mismatch with a larger PWI/DWI ratio may provide greater power for detecting beneficial effects of reperfusion.

1 December 2023 in Stroke
Verified
Journal Article
Closed access
LWLawrence R. Wechsler
Lawrence R. Wechsler
OAOpeolu Adeoye
Opeolu Adeoye
FAFana Alemseged
Fana Alemseged
MBMersedeh Bahr-Hosseini
Mersedeh Bahr-Hosseini
EDEmir Deljkich
Emir Deljkich
OROn Behalf Of The Xiith Stroke Treatment Academic Industry Roundtable
On Behalf Of The Xiith Stroke Treatment Academic Industry Roundtable
The Stroke Treatment Academic Industry Roundtable XII included a workshop to discuss the most promising approaches to improve outcome from acute stroke. The workshop brought together representatives from academia, industry, and government representatives. The discussion examined approaches in 4 epochs: pre-reperfusion, reperfusion, post-reperfusion, and access to acute stroke interventions. The participants identified areas of priority for developing new and existing treatments and approaches to improve stroke outcomes. Although many advances in acute stroke therapy have been achieved, more work is necessary for reperfusion therapies to benefit the most possible patients. Prioritization of promising approaches should help guide the use of resources and investigator efforts.

1 June 2025 in Stroke
Verified
Journal Article
Closed access
VYVignan Yogendrakumar
Vignan Yogendrakumar
BCBruce C.V. Campbell
Bruce C.V. Campbell
HJHannah T. Johns
Hannah T. Johns
LCLeonid Churilov
Leonid Churilov
FNFelix C. Ng
Felix C. Ng
SISELECT2 Investigators
SELECT2 Investigators
BACKGROUND: We aimed to determine whether extensive severe computed tomography (CT) hypodensity, representing blood-brain barrier injury, would be associated with a reduced benefit of endovascular therapy (EVT) in patients presenting with large core stroke. METHODS: This study is an exploratory analysis of SELECT2 (Randomized Controlled Trial to Optimize Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke), a randomized controlled trial of EVT versus medical management in patients with large ischemic core who presented to 31 comprehensive stroke centers across the United States, Canada, Europe, Australia, and New Zealand. Visible CT hypodensity was outlined, and a threshold of severe CT hypodensity was defined as the lower 99% CI of contralateral thalamic gray matter in Hounsfield units (HU). The association between the volume of severe CT hypodensity and modified Rankin Scale (mRS) score of 0 to 3 was evaluated using logistic regression models, with adjustment for age, National Institutes of Health Stroke Scale, total noncontrast CT core volume, and a volume-by-treatment interaction. The relationship between severe CT hypodensity volume and the probability of an mRS score of 0 to 3 was used to select clinically relevant volume cut points for further evaluation. The treatment effect of EVT versus medical management on independent ambulation and hemicraniectomy was assessed in 2 subgroups based on these volume cut points. RESULTS: In 322 patients, the median CT density was 31 HU (interquartile range, 28–34). The selected threshold of severe CT hypodensity was 26 HU. The volume of ischemic core ≤26 HU (per 1 mL increase) was associated with lower odds of mRS score of 0 to 3 after EVT (adjusted odds ratio [aOR], 0.96 [95% CI, 0.94–0.99]), but not medical management (aOR, 1.01 [95% CI, 0.98–1.03]; P interaction<0.01). In 101 patients with ≥26 mL of severe CT hypodensity, EVT, compared with medical management, was not associated with mRS score of 0 to 3 (aOR, 0.98 [95% CI, 0.33–2.88]) and was associated with hemicraniectomy (≥26 mL: aOR, 3.45 [95% CI, 1.09–10.86] versus <26 mL: aOR, 0.74 [95% CI, 0.31–1.75]; P interaction=0.03), whereas among 221 patients with <26 mL of severe hypodensity EVT was associated with mRS score of 0 to 3 (aOR, 7.20 [95% CI, 3.55–15.47]; P interaction<0.01). CONCLUSIONS: Severe hypodensity within large ischemic regions modifies the thrombectomy treatment effect and increases the likelihood of hemicraniectomy, independent of lesion volume. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03876457.

1 April 2023 in Stroke
Verified
Journal Article
Open access
WZWenting Zhang
Wenting Zhang
HPHongjian Pu
Hongjian Pu
XHXiaoming Hu
Xiaoming Hu
YSYejie Shi
Yejie Shi
RLRehana Leak
Rehana Leak
JCJun Chen
Jun Chen
Background: Stroke is the primary cause of chronic disability in the elderly, as there are no neurorestorative treatments for those who do not qualify for recanalization therapy. Experimental evidence in stroke animals suggests that transplantation of bone marrow–derived human mesenchymal stem cells (hMSCs) holds promise, but hMSC transplantation has not been systematically tested in aged animals. We tested the hypothesis that poststroke hMSC transplantation improves stroke recovery in aged mice by promoting brain repair. Methods: Permanent focal cerebral ischemia was induced in 20-month-old C57BL/6 male mice by distal middle cerebral artery occlusion. Bone marrow–derived hMSCs were expanded in vitro and then administrated intravenously into mice (1×10 6 cells in PBS) 24 hours after distal middle cerebral artery occlusion. Sensorimotor and cognitive functions, brain atrophy, and brain repair processes (neurogenesis, angiogenesis, oligodendrogenesis) were assessed for up to 56 days after stroke. Results: Poststroke hMSC transplantation did not mitigate brain atrophy or improve neuronal survival at 56 days after distal middle cerebral artery occlusion. However, hMSC-treated mice displayed superior neurobehavioral performances in the open field, rotarod, adhesive removal, novel object, and Morris water maze tests compared with PBS-treated controls. hMSCs promoted white matter integrity and enhanced angiogenesis and oligodendrogenesis—but not neurogenesis—in the stroke brain. Positive correlations between neurobehavioral performance and brain repair profiles or white matter integrity were observed in stroke mice. Conclusions: Poststroke hMSC transplantation improves long-term stroke recovery in aged mice, likely via mechanisms involving enhanced microvascular regeneration and white matter restoration.

14 July 2020 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
LWLawrence R. Wechsler
Lawrence R. Wechsler

10 March 2022 in Telemedicine and e-Health
Verified
Journal Article
Closed access
TTThomas Tropea
Thomas Tropea
AFAndrea Fuentes
Andrea Fuentes
ZRZachary Roberts
Zachary Roberts
MSMeredith Spindler
Meredith Spindler
KYKristy Yuan
Kristy Yuan
LWLawrence Wechsler
Lawrence Wechsler
Introduction: Teleneurology has become widely adopted during severe acute respiratory syndrome coronavirus 2 pandemic. However, provider impressions about the teleneurology experience are not well described. Methods: A novel questionnaire was developed to collect provider impressions about video teleneurology encounters. All providers in the University of Pennsylvania Health System (UPHS) Neurology Department ( N = 162) were asked to complete a questionnaire after each video teleneurology patient encounter between April and August 2020. Individual patient and encounter-level data were extracted from the electronic medical record. Results: One thousand six hundred three surveys were completed by 55 providers (response rate of 10.12%). The history obtained and the ability to connect with the patient were considered the same or better than an in-person visit in almost all encounters. The quality of the physician–patient relationship was good or excellent in 93%, while the overall experience was the same as an in-person visit in 73% of visits and better in 12%. Sixty-eight percent of respondents reported that none of the elements of the neurological examination if performed in person would have changed the assessment and plan. Assessment of the visit as the same or better increased from 83% in April to 89% in July and 95% in August. Headache (91%), multiple sclerosis and neuroimmunology (96%), and movement disorder (89%) providers had the highest proportion of ratings of same or better overall experience and neuromuscular providers the lowest (60%). Conclusions: Provider impressions about the teleneurology history, examination, and provider–patient relationship are favorable in the majority of responses. Important differences emerge between provider specialty and visit characteristics groups.